Search research articles
Contact Us
Filters
Showing results (11-20 of 73) with videos related to
Page
of 8
Sort By:
Antimicrobial Agents and Chemotherapy
|
October 17, 2007
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis
Deepak Almeida, Eric Nuermberger, Sandeep Tyagi, et al.
Journal of Advanced Pharmaceutical Technology & Research
|
January 17, 2012
The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
Sandeep Tyagi, Paras Gupta, Arminder Singh Saini, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis
Tetsuyuki Yoshimatsu, Eric Nuermberger, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2019
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay
Paul J Converse, Deepak V Almeida, Sandeep Tyagi, et al.
The Journal of Chemical Physics
|
April 29, 2010
An iterative, fast, linear-scaling method for computing induced charges on arbitrary dielectric boundaries
Sandeep Tyagi, Mehmet Süzen, Marcello Sega, et al.
Cellular Microbiology
|
January 22, 2005
The Mycobacterium tuberculosis SigD sigma factor controls the expression of ribosome-associated gene products in stationary phase and is required for full virulence
Heather Calamita, Chiew Ko, Sandeep Tyagi, et al.
Asian Journal of Transfusion Science
|
September 3, 2010
Use of blood components in critically ill patients in the medical intensive care unit of a tertiary care hospital
R N Makroo, R K Mani, Raina Vimarsh, et al.
Journal of Nanoscience and Nanotechnology
|
November 26, 2009
SAXS analysis of polypropylene-layered silicate nanocomposites: an integrated correlations functions approach using an exfoliation factor
A S Abdul Rasheed, Nisha Preschilla, G Sivalingam, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 19, 2013
Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis
Zahoor Ahmad, Sandeep Tyagi, Austin Minkowski, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 10, 2005
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model
Eric Nuermberger, Sandeep Tyagi, Kathy N Williams, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 73) with videos related to
Sort By:
Page
of 8
Antimicrobial Agents and Chemotherapy
|
October 17, 2007
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis
Deepak Almeida, Eric Nuermberger, Sandeep Tyagi, et al.
Journal of Advanced Pharmaceutical Technology & Research
|
January 17, 2012
The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
Sandeep Tyagi, Paras Gupta, Arminder Singh Saini, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis
Tetsuyuki Yoshimatsu, Eric Nuermberger, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2019
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay
Paul J Converse, Deepak V Almeida, Sandeep Tyagi, et al.
The Journal of Chemical Physics
|
April 29, 2010
An iterative, fast, linear-scaling method for computing induced charges on arbitrary dielectric boundaries
Sandeep Tyagi, Mehmet Süzen, Marcello Sega, et al.
Cellular Microbiology
|
January 22, 2005
The Mycobacterium tuberculosis SigD sigma factor controls the expression of ribosome-associated gene products in stationary phase and is required for full virulence
Heather Calamita, Chiew Ko, Sandeep Tyagi, et al.
Asian Journal of Transfusion Science
|
September 3, 2010
Use of blood components in critically ill patients in the medical intensive care unit of a tertiary care hospital
R N Makroo, R K Mani, Raina Vimarsh, et al.
Journal of Nanoscience and Nanotechnology
|
November 26, 2009
SAXS analysis of polypropylene-layered silicate nanocomposites: an integrated correlations functions approach using an exfoliation factor
A S Abdul Rasheed, Nisha Preschilla, G Sivalingam, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 19, 2013
Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis
Zahoor Ahmad, Sandeep Tyagi, Austin Minkowski, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 10, 2005
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model
Eric Nuermberger, Sandeep Tyagi, Kathy N Williams, et al.
Page
of 8